Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity?
- 240 Downloads
Mumps is one of the vaccine-preventable childhood diseases and it has not yet been eradicated in Germany. This raises the question as to whether the available mumps vaccines are effective enough to prevent mumps and which antibody test system allows the authentic assigning of mumps-specific immunity. In an attempt to answer this question, we analysed 227 sera samples from medical students of the University Hospital Frankfurt/Main, Germany, using different test systems: indirect immune fluorescence, neutralisation assay, routine ELISA and newly developed immunoassays, which contain the mumps nucleoprotein and the wild-type strain Enders ATCC VR106, respectively. Mumps vaccination coverage of the screened collective amounted to 75.1%, which differs notably from the detected mumps-specific seropositivity rates in the literature (range 53.3% to 82.4%). In contrast, a small group of unvaccinated students had much higher seropositivity rates. Of course, assigned vaccination coverage and calculated seropositivity rates are not effective enough to interrupt the transmission of the mumps virus. The often-occurring mumps outbreaks, some in highly vaccinated populations, may not always demonstrate vaccine failure. The investigation of newly developed test systems and the occurrence of different mumps virus genotypes should also be considered.
KeywordsVaccination Coverage Mumps Seroprevalence Rate Seropositivity Rate Mumps Virus
We highly appreciate the excellent technical assistance of Mrs. Gabriele Bauer and Mrs. Cornelia Rühl, and would like to express our most sincere thanks to Dr. Joseph Allen Hockley for carefully proofreading the manuscript.
Source of support
We would like to thank EUROIMMUN for their encouragement and for the allocation of the serological test kits.
- 8.World Health Organization (WHO) (2007) Mumps virus vaccines. Wkly Epidemiol Rec 82(7):51–60Google Scholar
- 14.Rubin SA, Qi L, Audet SA, Sullivan B, Carbone KM, Bellini WJ, Rota PA, Sirota L, Beeler J (2008) Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis 198(4):508–515PubMedCrossRefGoogle Scholar
- 15.Steinhagen K, Biermann-Göcke S, Dönig M, Zein M, Schlumberger W, Stöcker W (2008) Mumps-spezifische Immunität etabliert sich erst 120 Tage nach MMR-Impfung! Antikörper-Bestimmung unter Verwendung von Antigenen des Impfstammes anstelle des Wildtyps. Pädiatrie hautnah 3.2008; 173 (abstract band, 16. DGPI congress)Google Scholar
- 24.Centers for Disease Control and Prevention (CDC) (2010) Update: mumps outbreak—New York and New Jersey, June 2009–January 2010. MMWR Morb Mortal Wkly Rep 59(5):125–129Google Scholar